Romidepsin Injection 10mg (Istodax® / イストダックス点滴静注用10mg)

JPY ¥145,300

Japanese Antineoplastic Agent / HDAC Inhibitor (Romidepsin 10mg). For intravenous infusion in relapsed or refractory peripheral T-cell lymphoma. 1 vial (with dedicated solvent). Mfd. by Bristol-Myers Squibb K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥133,676
10 - 19 12% JPY ¥127,864
20 + 18% JPY ¥119,146
SKU: IST-10-INJ Category:

Description

Product Overview / 商品概要

Istodax Injection 10mg (イストダックス点滴静注用10mg)
Generic: Romidepsin / ロミデプシン
Therapeutic Category: Antineoplastic Agent / Histone Deacetylase (HDAC) Inhibitor / 抗悪性腫瘍剤/ヒストン脱アセチル化酵素(HDAC)阻害剤
Manufactured by: Bristol-Myers Squibb K.K. / ブリストル・マイヤーズ スクイブ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Romidepsin 11mg per vial (overfilled; yields 10mg per vial when reconstituted) / 1バイアル中 ロミデプシン 11mg(過量充填)
Additives: Povidone 22mg, pH adjuster q.s. (drug product); Dedicated solvent: Propylene glycol 1.97g, Dehydrated ethanol 0.37g / ポビドン 22mg、pH調整剤 適量(本剤);専用溶解用液:プロピレングリコール 1.97g、無水エタノール 0.37g
Appearance: White solid, mass or powder; pH 5.2–5.4 (after reconstitution and dilution); Osmolarity ratio 1.3–1.7 relative to saline (after reconstitution and dilution)
外観: 白色の固体、塊又は粉末;pH 5.2~5.4(溶解・希釈後);浸透圧比 1.3~1.7(生理食塩液に対する比、溶解・希釈後)

Indications / 効能効果

EN: Relapsed or refractory peripheral T-cell lymphoma
JA: 再発又は難治性の末梢性T細胞リンパ腫

Dosage and Administration / 用法用量

EN: The usual adult dose is romidepsin 14mg/m² (body surface area), administered as a 4-hour intravenous infusion on Days 1, 8, and 15, followed by a rest period (Days 16–28). This 28-day period constitutes one cycle, which is repeated. Dose reduction should be made as appropriate based on the patient’s condition.
JA: 通常、成人にはロミデプシンとして14mg/m²(体表面積)を1、8、15日目に4時間かけて点滴静注した後、休薬(16~28日目)する。この28日間を1サイクルとして投与を繰り返す。なお、患者の状態により適宜減量する。

Contraindications / 禁忌

EN: 2.1 Patients with a history of hypersensitivity to any component of this product; 2.2 Pregnant women or women who may be pregnant
JA: 2.1 本剤の成分に対し過敏症の既往歴のある患者;2.2 妊婦又は妊娠している可能性のある女性

Regulatory Information / 規制情報

Approval No.: 22900AMX00586000
Sales Started: April 2018 / 2018年4月
Classification Code: 874291
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 1 vial (with dedicated solvent) / 1バイアル(専用溶解用液付)
Other Available Packages (by special order): 1 vial (with dedicated solvent)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Romidepsin Injection 10mg (Istodax® / イストダックス点滴静注用10mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Romidepsin Injection 10mg (Istodax®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.